Prehypertension as defined by clinic blood pressure (BP) measurements frequently involves the undiagnosed clinical qualification of masked hypertension (MH). 1 The data so far, indicate that MH is associated with increased cardio vascular risk almost identical to the risk resulting from sustained hypertension 2 and possibly higher than true prehypertension. 3 However, the clinical usefulness of MH is rather debated because its prevalence and reproducibility varies along with the different methodology used for the clinic BP assessment and the subsequent comparison with either ambulatory or home BP measurements. Consequently, in the everyday practice remains unclear in which clinical circumstances the identification of MH should be encouraged. 4 MH is associated with several clinical characteristics including almost constantly the presence of active smoking. 5 However, smoking status has a multinomial categorical distribution in the general population including passive smoking. 6 Despite that the dose of smoke delivered to active smokers is ≥100 times that delivered to a passive smoker, the relative risk of coronary heart disease with respect to nonsmokers is significantly increased for both active and passive smokers by 78 and 31% respectively. 7 Clinical and experimental data indicate that passive smoking exerts detrimental effects on vascular homeostasis; 8 however, its association with BP levels and particularly in a clinically nonhypertensive range is still lacking. Accordingly, we aimed to investigate ambulatory BP levels in clinically normotensive nonsmokers exposed and not exposed to passive smoking aiming to evaluate the relative prevalence of MH in this setting. We hypothesized that passive smokers would demonstrate higher prevalence of MH with respect to smoke-free living subjects, possibly representing a hidden hemodynamic link between passive smoking and increased cardiovascular risk.
Background
We investigated ambulatory blood pressure (BP) levels among clinically normotensive nonsmokers exposed (PS) and not exposed (SF) to passive smoking aiming to evaluate the relative prevalence of masked hypertension (MH).
methodS
From 790 consecutive never-treated subjects who were self-referred to an outpatient hypertensive clinic, we excluded active smokers and those having a mean clinic BP >140/90 mm Hg. In the remaining population, echocardiography and routine biochemical profile assessment was performed, whereas by the implementation of additional exclusion criteria, all clinically normotensive subjects eligible to participate (i.e., 154 PS and 100 SF) underwent to ambulatory BP monitoring.
reSultS
PS with respect to SF subjects were younger, followed a less hygienic diet and consumed more alcohol (all P < 0.05). Moreover, PS in comparison with SF showed higher 24-h systolic BP, standing diastolic BP, and clinic heart rate (126 ± 6 mm Hg vs. 122 ± 5 mm Hg, 89 ± 4 mm Hg vs. 84 ± 4 mm Hg and 79 ± 5 beats/min vs. 73 ± 4 beats/min, respectively, P < 0.05 for all) and higher prevalence of MH (23% vs. 8%, P < 0.01). after adjustment for confounders determinants of MH remained passive smoking, weekly duration and intensity of passive smoke exposure, younger age, clinic heart rate, low physical activity score, and standing/ sitting difference of diastolic BP and heart rate (P < 0.05 for all).
articles Passive Smoking and Masked Hypertension for all participants; participants were also given clinical and echocardiographic examinations. Apart from a strictly scheduled clinic BP evaluation and ambulatory BP monitoring, a routine biochemical profile was assessed as well. The study protocol complies with the Helsinki Declaration, was approved by our institutional ethics committee and all participants gave written informed consent.
Participants. We studied 790 consecutive never treated with antihypertensive drugs white subjects aged ≥30 years, who were self-referred to our outpatient hypertensive unit for BP evaluation. Nonsmokers were considered those who gave a negative response when asked whether they had ever smoked at least 100 cigarettes, 20 cigars, or 20 pipes of tobacco in their life in combination with a negative response when asked about whether they had smoked any cigarettes, cigars or pipes in the past 5 days; 8 any who responded positively (smokers, n = 238) were excluded. The remaining 552 subjects-divided in those with at least 1 h daily domestic and/or workplace smoke exposure 9 (passive smokers, PS, n = 350), and in those living in a smoke-free domestic and/or workplace environment (i.e., not exposed to passive smoking, SF, n = 202)-underwent to clinic BP evaluation based on three separate outpatient measures and accordingly subjects with a mean clinic systolic or diastolic BP >140 and 90 mm Hg respectively were also excluded (i.e., n = 120 from the former group and n = 60 from the latter group, respectively). 10 Additional exclusion criteria included a history of any cardio vascular disease, impaired glucose metabolism ( fasting glucose >110 mg/dl), high clinical evidence for familial dyslipidemia, left ventricular hypertrophy (left ventricle mass index >110 g/m 2 for men and >104 g/m 2 for women) or any other clinically significant concurrent medical condition such as psychiatric, neuromuscular, kidney (estimated glomerular filtration rate <60 ml/min), respiratory, hepatic, or gastro intestinal disease. None of the participants had any history or clinical/laboratory evidence of recent infection, inflammation, or underwent any medical treatment (including lipid lowering, anti-inflammatory treatment, and hormone replacement therapy) 1 month before entry into the study. After the implementation of these measures, the eligible to participate population consisted of nonsmokers exposed (PS, n = 154) and not exposed (SF, n = 100) to passive smoking with mean clinic systolic and diastolic BP <140 and 90 mm Hg respectively. Among PS, 73% (n = 112) of subjects were exposed to domestic smoke alone, 15% (n = 24) to workplace smoke alone, and 12% (n = 18) to both domestic and workplace smoke (flow-chart, Figure 1) .
Variables of interest.
The main disease-oriented variable was the occurrence of MH, whereas the main determinant was the exposure to domestic and/or workplace passive smoking. Number of cigarettes smoked in a week by cohabitants and/or coworkers (i.e., intensity measure of smoke exposure), weekly duration (hours) of exposure and the overall time of exposure (years) were also registered. 9 Alcohol consumption was assessed by questioning all participants about the likelihood to consume alcohol beverages. An alcoholic beverage was defined as a 12-oz glass of beer, a 6-oz glass of wine, or a shot of liquor and the consumption was reported as the number of alcoholic beverages consumed per day. 11 Similarly, to assess the likelihood of hygienic dietetic profile, total fruit and vegetable consumption was estimated by summing the number of the weekly occasions that the participant reported eating a fruit or vegetable. 8 A short foodfrequency questionnaire was implemented to assess daily sodium intake for each participant by summing absolute amounts of sodium per serving for each food category over a week period, as described previously in detail. 12 Coffee intake was also reported as the number of cups of coffee consumed per day. Physical activity was classified as sedentary (score = 0), lightly active (score = 1), moderately active (score = 2), and vigorously active (score = 3), and was derived from a series of questions relating to type, intensity, and frequency of different activities and sports. 8 Finally, three diverse components (i.e., education, income, job status) of socioeconomic status were The final PS population (n = 154) consisted of 112 subjects exposed to domestic smoke alone, 24 subjects exposed to workplace smoke alone and 18 subjects exposed to both domestic and workplace smoke. BP, blood pressure; n, number of cases; PS, passive smokers; SF, smoke-free living subjects. 
Measurements
Clinic and ambulatory BP: BP measurements were made in our outpatient clinic according to the recent guidelines, at three separate visits with a mean elapsing time of 1 week. 13, 14 In each visit participants were encouraged to relax for 30 min an experienced cardiologist performed three different BP measurements at 5-min intervals by using a mercury sphygmomanometer. Korotkoff phase 1 and 5 were used to determine systolic and diastolic BP, respectively; in each visit the second and third BP measurements were averaged and the final clinic BP consisted of the mean of the three visits. Mean clinic heart rate was determined by averaging the three separate registered values of heart rate. Furthermore, a standing heart rate and BP evaluation was performed in each visit after 2-min standing from the last sitting BP measurement. The mean standing heart rate and BP was calculated by averaging the three values related to each visit. Finally, the mean difference between the standing and sitting BP and heart rate was registered. Over a working day (Monday through Friday) and just after the completion of clinic BP measurements, ambulatory BP was recorded by using the automatic Spacelabs units 90207 (SpaceLabs, Redmond, WA) by means of a procedure previously described in detail. 15 Investigators performing ambulatory BP monitoring were blinded to the clinical status of the examinees. In brief, the cuff with the appropriate bladder size was fixed to the nondominant arm and the device was set to obtain automatic heart rate and BP readings at 15 min intervals during the daytime and at 30 min intervals during the night time. In keeping with the current practice, daytime and night time were defined using short fixed-clock time intervals, which ranged from 10 am to 8 pm and from midnight to 6 am, respectively. 24-h systolic/ diastolic BP values were the mean of the overall 24-h recordings after artifact editing. More than 80% of successful daytime readings were required to include a test as adequate for subsequent analysis.
MH was defined as mean clinic systolic and diastolic BP of <140 and 90 mm Hg respectively, conjointly with daytime systolic or diastolic BP >135 and 85 mm Hg, respectively. 1 Subjects with night time BP fall >10% were defined as dippers and those with night time BP fall <10% as nondippers.
Cardiac ultrasonography: Echocardiographic study was performed by an experienced operator who was blind to the clinical status of the examined subject using a General Electric Medical System Vivid 3 PRO ultrasound imager (General Electric Medical System, Milwaukee, WI) equipped with a 2.5-5 MHz transducer, according to the guidelines of the American Society of Echocardiography. Left ventricle mass was measured using the formula of Devereux indexed for body surface area to estimate left ventricle mass index, while relative wall thickness was calculated as well. 16 Biochemical assessment: Venous blood samples were obtained from each participant in the morning (from 7 to 8 am) after an overnight fasting for the determination of plasma glucose, serum creatinine, and lipid profile (i.e., total cholesterol, triglycerides, low-and high-density lipoprotein cholesterol). Plasma glucose, total cholesterol, high-density lipoprotein cholesterol, and triglycerides were determined by spectrophotometric methods. Low-density lipoprotein cholesterol and estimated glomerular filtration rate were calculated by the Friedewald and Cockcroft-Gault formulas, respectively.
Statistical analysis. SPSS statistical package, release 15.0 (SPSS, Chicago, IL) was used for all statistical analysis. For lifestyle attitudes and socioeconomic status we calculated the median to define partition and additionally we provided the interquartile ranges. Significant differences between the study subgroups were determined using the Student independent samples t-test and Mann-Whitney test for the not normally distributed categorical variables. Univariate associations of MH with diverse cofactors were assessed by binary logistic regression analysis. Multivariable logistic regression models were implemented to test the impact of passive smoking on masked hypertensive phenotype after adjustment for significantly associated cofactors in the univariate analysis. Any potential multicollinearity between the explanatory variables was explored before testing. A P value <0.05 was accepted as indicating statistical significance.
reSultS Participants
From 230 clinically normotensive PS, 68 subjects were excluded (i.e., 27 because of cardiovascular diseases including left ventricular hypertrophy; 3 because of respiratory disturbances; 19 because of disturbed glucose metabolism; and 19 because of medical treatment), whereas 8 subjects although eligible for participation refused to give informed consent. On the other hand, from 142 clinically normotensive SF, 40 subjects were excluded (i.e., 19 because of cardiovascular diseases including left ventricular hypertrophy; 1 because of respiratory disorder; 9 because of disturbed glucose metabolism; 10 because of medical treatment, and 1 because of psychiatric disorder), whereas 2 subjects although eligible for participation refused to give informed consent. Consequently, 154 PS and 100 SF clinically normotensive subjects underwent ambulatory BP monitoring (Figure 1 flow chart) .
main results: outcome data
The two groups did not differ regarding sex, waist circumference, body mass index, physical activity and socioeconomic articles Passive Smoking and Masked Hypertension status score, sodium and coffee intake, whereas SF group resulted older by 5 ± 5 years with respect to PS group (P < 0.001). Alcohol consumption was higher in PS compared to SF subjects and additionally the latter group demonstrated a higher score related to more hygienic food consumption ( Table 1) .
Mean clinic BP measurements resulted similar between the groups, whereas mean clinic heart rate was significantly higher in PS with respect to SF group. The difference between standing and sitting of both diastolic BP and heart rate was significantly enhanced in PS with respect to SF subjects. The rate of successful daytime ambulatory BP readings was of 91.5 ± 5.5%. PS group with respect to SF group showed significantly higher levels of 24-h systolic BP, while 24-h diastolic BP did not differ. Daytime systolic and diastolic BP were significantly higher in the PS compared to the SF group, while the respective night time BP measurements and the prevalence of nondipping status were similar. The prevalence of MH was 23% for the PS and 8% for the SF subjects, P < 0.01 ( Table 1) .
In the PS group, weekly exposure to passive smoke was 33.4 ± 21.5 h over a period of 14 ± 4 years. Intensity of the exposure to passive smoke was 75 ± 36 cigarettes/week. Metabolic profile and kidney function parameters resulted similar between the two groups ( Table 2) . Finally, left ventricle mass index and relative wall thickness did not differ between the PS and SF group (86 ± 15 g/m 2 vs. 84 ± 14 g/m 2 , P = 0.3 and 0.40 ± 0.02 vs. 0.39 ± 0.03, P = 0.12, respectively).
Univariate logistic regression analysis (Table 3 ) revealed that MH was positively associated with clinic systolic BP, clinic heart rate, passive smoking, weekly in hours, and overall in years duration of passive smoke exposure, intensity of passive smoke exposure, nondipping status, standing/sitting difference of diastolic BP and heart rate, as well as negatively associated with age and high physical activity score (P < 0.05 for all).
After adjustment for confounders additionally to passive smoking, determinants of MH remained: weekly duration and intensity of the exposure to passive smoke, low physical activity score, younger age, increased clinic heart rate, and diastolic BP response to standing ( Table 4) . In a further For alcohol consumption, sodium intake, hygienic diet score, physical activity score, and socioeconomic status score we reported the median and interquartile ranges (from 25th to 75th percentile); for continuous descriptive variables are provided the standard deviations, while the rest of categorical variables are reported with absolute and relative (percentages) frequencies. BP, blood pressure; bpm, beats per minute; n, number of cases; PS, passive smokers; SF, smoke-free living subjects. articles Passive Smoking and Masked Hypertension model (R 2 = 42.2%) produced by replacing clinic heart rate with the difference between standing and sitting heart rate along with the remained variables presented in Table 4 , heart rate response to standing resulted a significant determinant of masked hypertensive phenotype (adjusted odds ratio of 1.08 with 95% confidence interval from 1.04 to 1.19, P < 0.01).
diScuSSion
The main finding was that the clinically normotensive PS compared to SF subjects demonstrated higher prevalence of MH (23% vs. 8%, respectively) which in turn was associated with the weekly duration and intensity of smoke exposure. A secondary finding was that younger age, increased clinic heart rate, hemodynamic postural reactions to standing as well as lower physical activity score resulted significant determinants of MH. These findings suggest that passive smoking may represent an obscured substrate for the expression of masked hypertensive phenotype in nonsmokers. This is the first study examining the effect of passive smoking on the prevalence of MH in clinically normotensive nonsmokers. The significant positive association of passive smoking observed in our study extends a step beyond previous evidence supporting first, that the selectively increased daytime BP levels are associated with current smoking, 10 and second, that being a current smoker heighten the probability for MH by 16% with respect to the nonsmoking status. 17 Additionally, given that MH was associated with passive smoking in a "dose-related" manner, their coexistence may enhance in incremental mode the cardiovascular risk beyond the level that could be attributed to MH alone. 8, 9, 18 The association between increased clinic heart rate with MH may be triggered at least partially from sympathetic overdrive related to smoke exposure. 19, 20 Finally, adverse hemodynamic postural BMI, body mass index; DBP, clinic diastolic blood pressure; duration of exposure hours/ week, duration of exposure to household and/or workplace smoke in a weekly period; duration of exposure years, overall period of exposure in years of the participants; eGFR, estimated glomerular filtration rate; high alcohol consumption, alcohol consumption more than the median (i.e., 1.78 U/day); high coffee consumption, coffee consumption more than the median (i.e., 1.8 cups/day); high hygienic diet score, the consumption of fruits or vegetables more than the median (i.e., 12 occasions/ week); high physical activity, a score more the median (i.e., 1.27: less than the midway between physical activity scoring 1 and 2); high socioeconomic status, a score more than the median (i.e., scoring >5); high sodium intake, intake more than the median (i.e., 6.82 g/ day); HR, clinic heart rate; intensity of exposure, number of cigarettes smoked in the presence of the participants by home-companions and/or coworkers in a week; LDL, low-density lipoprotein; LVMI, left ventricle mass index; nondipping status, those with night time BP fall <10%; OR, odds ratios; passive smoking, positive exposure to smoke; S/S, standing/sitting; SBP, clinic systolic blood pressure; WC, waist circumference. Variables entered into the model were those demonstrated significant univariate associations with masked hypertensive phenotype, as depicted in table 3, after having checked for multicollinearity issues: standing/sitting difference of heart rate was not implemented into the model because resulted highly interrelated with clinic heart rate. BP, blood pressure; duration of exposure hours/week, duration of domestic and/or workplace exposure to smoke in a weekly period; high physical activity, a score more the median (i.e., 1.27: less than the midway between physical activity scoring 1 and 2); intensity of exposure, number of cigarettes smoked in the presence of the participants by home-companions and/or coworkers in a week; nondipping status, those with night time BP fall <10%; OR, odds ratio; overall duration of exposure in years, overall period of positive smoke exposure in years; R 2 , overall model fit; S/S, standing/sitting.
articles Passive Smoking and Masked Hypertension reactions observed in PS constituted determinants of MH, in line with the HARVEST study, highlighting the role of orthostatic testing in young subjects with mild hypertension. 21 In contrast with previous evidence, 22 the association of high alcohol consumption with MH was not confirmed in our study, possibly because of the relatively low self-reported consumption; moreover, in Mediterranean countries lowto-moderate consumption of alcohol-mainly wine-was associated with lower cardiovascular morbidity. 23 Decreased physical activity, such as sedentary life, constituted a determinant of masked hypertensive phenotype; indeed, not physically active subjects may lack of the potential benefit of exercise on daytime BP levels. 24, 25 Lower consumption of fruit and vegetables, increased sodium intake, and coffee consumption were not found associated with MH; those attitudes need to be evaluated in a larger cohort, whereas their effect on BP is possibly confounded by other factors. Low socioeconomic profile was not associated with passive smoking in our cohort, probably because of the increased prevalence of active smoking, regardless of the socioeconomic status, observed in our country. In line with the PAMELA study, 26 but in contrast with other transverse studies, 27 we found no correlation between left ventricle mass with MH; the latter, is possibly due to the preliminary exclusion of subjects with increased left ventricle mass index. In the multivariable analysis, the association of nondipping profile with MH faded away, because only daytime ambulatory values were implemented to define MH; indeed, passive smoking constitutes a daytime attitude and is rather unlike to extend its detrimental effects on BP levels in the night time. Finally, the yet debating finding 28, 29 that MH was associated with younger age is possibly due to high influence of the out-of-clinic stressor factors including smoke exposure in younger compared to older subjects.
Identifying adverse clinical BP patterns such as MH from elementary data (i.e., demographic and lifestyle characteristics) could be of particular interest for the cost/ effectiveness of BP assessment in the daytime clinical practice. Accordingly, in PS either ambulatory or alternatively home BP measurements may be implemented to uncover adverse out-of-clinic BP phenotypes contributing to the amelioration of risk stratification. 3 Several study limitations are acknowledged. First, passive smoking as assessed by the design of the present study did not exclude the environmental public smoke contamination (i.e., restaurants and bars) as well as the occasional smoke exposure. Second, we did not perform a quantitative measurement of smoking exposure like the levels of serum cotinine which constitute a standard approach to detect smoke contamination; however, cotinine in nonsmokers might derive from dietary and other noninhaled sources of nicotine. 8, 9 Misclassification of smokers falsely self-reporting to be nonsmokers could not be definitely excluded. 9, 30 Third, we studied subjects who were self-referred to our outpatient hypertension clinic, thus the results might not be directly extendable in the community. Fourth, lack of data regarding 24-h sodium excretion for better salt intake quantization constitutes a further potential limitation. Finally, causal relationship between passive smoking and MH could not be easily derived owing to the cross-sectional nature of the study.
In conclusion, MH is associated with passive smoking in a dose-related manner and low physical activity, increased heart rate and postural hemodynamic reaction may represent potential accelerators of that phenomenon. These findings underscore the need for amelioration of smoking status assessment in combination with other demographic and lifestyle characteristics during the routine clinic BP evaluation.
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